RAD51 and prostate cancer: Among all these inhibitors, DIDS effect against RAD51 activity was demonstrated very early [20] but this molecule is relatively cytotoxic in fibroblast and prostatic cancer cells (data not shown), weakly specific, and was proved to be unstable in aqueous solution [30].